Gary Ingenito, Chief Med. & Reg. Officer at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 450,000 shares at $21.67 ($9.8M) on 2025-03-06, disclosed to the SEC on 2025-03-07.
Open-market sale of $9.8M CPRX by Chief Med. & Reg. Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.09 | 44,904 | $992K | 10.1% |
| 2 | $22.09 | 44,904 | $992K | 10.1% |
| 3 | $21.67 | 180,096 | $3.9M | 39.9% |
| 4 | $21.67 | 180,096 | $3.9M | 39.9% |
| Total | $21.75 avg | 450,000 | $9.8M | 100% |
| Filing → |
| CPRX | SELL | 2024-11-22 | $806K | — | Filing → |
| CPRX | SELL | 2024-08-13 | $1.8M | — | Filing → |
| CPRX | SELL | 2024-06-07 | $1.3M | — | Filing → |